Desenex
About Desenex
Desenex is a Healthcare company founded in 1999, and was acquired by Crown Laboratories in December 2018. Footcare products are manufactured and distributed by Desenex. Its chief executive, as recorded, is Jeff Bedard. Its focus areas include Traditional Pharmaceuticals.
Company details
Desenex was founded in 1999 as a manufacturer specializing in footcare products. Operations are centered on producing items designed for foot health and hygiene. The company is led by CEO Jeff Bedard, with its online platform accessible via desenex.com. Focus remains on the consumer goods sector, particularly personal care essentials, without specified geographic operations. Product development and distribution are handled internally to meet market needs.
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website desenex.com
- Acquired by Crown Laboratories (Dec 2018)
- InvestorsCrown Laboratories
& 1 more
- Acquired byCrown Laboratories
(Dec 2018)
Investors in Desenex
Desenex has secured backing from 2 investors. Prominent investors backing the company include Crown Laboratories and Hildred Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
OTC, prescription, skin care, and oral care products are manufactured. | 2000 | crownlaboratories.com | Johnson City, United States | |
A family investment firm managing diverse securities investments. | hildredpartners.com | New York, United States |
Investor details for Desenex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Desenex
1 people are tracked at Desenex (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jeff Bedard | CEO | Leadership |
Complete people profiles for Desenex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Desenex
2 dated milestones of Desenex across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Desenex is founded.
- Exit Acquired by Crown Laboratories.
Web traffic of Desenex
The website of Desenex (desenex.com) receives about 7.1K visits a month.
- Monthly visits7.1K
▲ 440.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Desenex
Complete news archive for Desenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Desenex
Desenex was founded in 1999.
Jeff Bedard is the CEO of Desenex, as recorded in our data.
Desenex was founded in 1999 as a manufacturer specializing in footcare products. Operations are centered on producing items designed for foot health and hygiene. The company is led by CEO Jeff Bedard, with its online platform accessible via desenex.com. Focus remains on the consumer goods sector, particularly personal care essentials, without specified geographic operations. Product development and distribution are handled internally to meet market needs.
Desenex has 2 investors. Key investors include Crown Laboratories, and Hildred Capital Partners.
Yes. Desenex was acquired by Crown Laboratories in December 2018.